MedPath

Endoscopic Closure of Tracheoesophageal Fistulas With Occluder Device

Phase 4
Terminated
Conditions
Acquired Tracheo-esophageal Fistula
Interventions
Device: Fistula closure with Gore Helex Septal Occluder
Device: Gore Helex Septal Occluder
Registration Number
NCT01153061
Lead Sponsor
University of Sao Paulo
Brief Summary

Endoscopic closure of tracheoesophageal fistulas with a device used for closure of cardiac septal defects.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
4
Inclusion Criteria
  • Patients over 14 years old
  • Benign tracheoesophageal fistulas identified through bronchoscopy;
Exclusion Criteria
  • Malign neoplasia
  • Current mechanical ventilation
  • Immunosuppressed
  • Current local inflammatory process at fistulas borders
  • Other clinical risk factors

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Fistula closure with occluderGore Helex Septal OccluderPatients with benign tracheoesophageal fistulas will be submitted to the correction with the occluder.
Fistula closure with occluderFistula closure with Gore Helex Septal OccluderPatients with benign tracheoesophageal fistulas will be submitted to the correction with the occluder.
Primary Outcome Measures
NameTimeMethod
Closure of tracheoesophageal fistulas with the Gore Helex Septal Occluder6 months

The closure will be confirmed by endoscopic or bronchoscopic observation of the fistula at regular intervals: one week, two weeks, and four weeks after implant of the occluder.

A thorax CT scan will ascertain correct positioning and stability of the occluder.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Heart Institute (InCor)-Clinics Hospital Sao Paulo University Medical School

🇧🇷

Sao Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath